Connecting with People Who Have Suffered from Diseases Can Change Attitudes Toward Vaccines
A BYU study found introducing vaccine-hesitant people to people affected by vaccine-preventable diseases can decrease vaccine hesitancy.
Genetics Linked to Immunity to Childhood Vaccines
Researchers at the University of Oxford in the United Kingdom have linked several genetic variations with the level of protective antibodies generated following routine childhood immunizations.
2018-19 Flu Season Separated by Two Waves Was Longest in Decade
The 2018-19 influenza (flu) season was both the longest in a decade and marked by two separate waves of influenza A, CDC says.
FDA Approves Pediatric Hexavalent Combination Vaccine
Sanofi and Merck’s Vaxelis has been approved by the U.S. Food and Drug Administration.
Researchers Discover New, Rare Autoimmune Disease
A previously unknown autoimmune muscle disease involving sudden onset of debilitating muscle pain and weakness has been identified by researchers at Washington University School of Medicine in St. Louis, Mo.
Flu Pamphlet Impacts Parents’ Decision to Vaccinate Kids
A new study by researchers at Columbia University has found handing a pamphlet about influenza (flu) to parents in pediatricians’ waiting rooms can have a significant impact on increasing the uptake of the flu vaccine.
HHS Grants Additional Money to Expand Access to Effective Opioid Treatment
The U.S. Department of Health and Human Services released an additional $487 million to supplement first-year funding through its State Opioid Response grant program.
FDA Seeks to Enhance Clinical Trial Diversity with New Guidance
The U.S. Food and Drug Administration has issued draft guidance to overcome obstacles to increasing enrollment diversity in clinical trials.
New CMMI Direct-Contracting Pay Models Will Overhaul Fee-for-Service Models
The Centers for Medicare and Medicaid Innovation is introducing new pay models that will shift primary care from fee-for-service payments to a global fee model under which clinicians and hospitals could assume varying amounts of risk.
SCIG with Recombinant Human Hyaluronidase Is Safe and Preferred vs IVIG by Some Multifocal Motor Neuropathy Patients
A team of Dutch investigators enrolled 18 multifocal motor neuropathy (MMN) patients on intravenous immune globulin(IVIG) treatment in a prospective open-label study to evaluate the comparative safety of treatment with 10% human immune globulin whose subcutaneous administration is facilitated with recombinant human hyaluronidase (fSCIG) (HyQvia).